Related Experiment Videos
Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata
Hongbo Wang1, Mamatha Mahadevappa, Karen Yamamoto
1Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California, USA.
Fertility and Sterility
|August 12, 2003
Summary
Gene expression profiling reveals distinct patterns in uterine leiomyomata (fibroids) compared to normal myometrium. This study identified 68 genes significantly altered in fibroids, suggesting their involvement in tumor development.
Area of Science:
- Gynecologic Oncology
- Molecular Biology
- Genomics
Background:
- Uterine leiomyomata, commonly known as fibroids, are benign tumors originating from the myometrium.
- Understanding the molecular mechanisms underlying fibroid development is crucial for targeted therapies.
Purpose of the Study:
- To comprehensively analyze gene expression and regulation in uterine leiomyomata and matched normal myometrium.
- To identify specific genes associated with fibroid formation and growth.
Main Methods:
- Oligonucleotide microarray analysis of gene expression in paired leiomyoma and myometrium tissue samples from seven patients.
- Validation of key gene expression changes using reverse transcriptase-semiquantitative polymerase chain reaction and immunohistochemistry.
Main Results:
- Significant differential expression of 68 genes was observed between leiomyomata and normal myometrium.
- Specifically, 23 genes were upregulated and 45 genes were downregulated in leiomyomata.
- Cluster analysis confirmed these genes' relevance in distinguishing leiomyoma from myometrium.
Conclusions:
- High-density oligonucleotide microarrays effectively capture unique gene expression signatures in uterine leiomyomata.
- These distinct patterns highlight the molecular differences between leiomyomata and normal myometrium.
- The identified genes are implicated in the tumorigenesis of uterine leiomyomata.